- Treatment patterns and outcomes of patients with relapsed or ...🔍
- Treatment Patterns and Outcomes in Patients with Relapsed ...🔍
- Treatment Patterns and Outcomes in Patients with Relapsed or ...🔍
- Treatment Patterns and Outcomes of Patients with Relapsed ...🔍
- Current real|world treatment patterns and outcomes in patients with ...🔍
- Articles Treatment patterns and outcomes of patients with relapsed ...🔍
- results from the international SCHOLAR|5 study🔍
- Recent real|world treatment patterns and outcomes in US patients ...🔍
Treatment Patterns and Outcomes in Patients with Relapsed or ...
Treatment patterns and outcomes of patients with relapsed or ...
Patients with relapsed or refractory follicular lymphoma receive heterogeneous treatments in the third-line setting or later.
Treatment Patterns and Outcomes in Patients with Relapsed ...
Treatment patterns and outcomes in patients with relapsed/refractory multiple myeloma receiving ≥3 lines of therapy: a real-world evaluation in the United ...
Treatment Patterns and Outcomes in Patients with Relapsed or ...
Introduction: First-line (1L) therapy for diffuse large B-cell lymphoma (DLBCL) can cure ~60% of patients (pts), but ~10-15% do not respond ...
Treatment Patterns and Outcomes of Patients with Relapsed ...
Our purpose was to describe treatment patterns, survival outcomes and duration of response in patients with non-transformed multiply R/R FL receiving three or ...
Treatment patterns and outcomes of patients with relapsed or ...
5-year overall survival was 58% in the 37 patients treated with lenalidomide with or without anti-CD20 as their index therapy; patients treated with the other ...
Current real-world treatment patterns and outcomes in patients with ...
Background: Limited real-world data exist on treatments for relapsed/refractory multiple myeloma (RRMM) since the recent approval of new agents.
Articles Treatment patterns and outcomes of patients with relapsed ...
Patients with relapsed or refractory follicular lymphoma receive heterogeneous treatments in the third-line setting or later. We observed high response rates to ...
Treatment patterns and outcomes of patients with relapsed or ...
Fingerprint. Dive into the research topics of 'Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or ...
results from the international SCHOLAR-5 study | Haematologica
Treatment patterns and clinical outcomes observed in the international SCHOLAR-5 study – a large, contemporary cohort of later line r/r FL ...
Recent real-world treatment patterns and outcomes in US patients ...
In patients with relapsed/refractory multiple myeloma (RRMM) previously receiving 1–3 therapy lines, newer agents demonstrated improved outcomes versus older ...
Treatment Patterns and Outcomes Among Patients with Relapsed ...
... patients with relapsed/refractory (R/R) FL. ... The objective of this study was to assess real-world treatment patterns and outcomes among ...
REAL-WORLD TREATMENT PATTERNS AND OUTCOMES IN ...
REAL-WORLD TREATMENT PATTERNS AND OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA WITH AT LEAST TWO PRIOR THERAPIES IN BRAZIL. Visits. 480.
Evolving treatment patterns and improved outcomes in relapsed ...
There is no consensus on preferred 2 L therapy at the time of relapse, with treatment selection impacted by patient factors, frontline therapy, ...
Treatment patterns and outcomes according to cytogenetic risk ...
In clinical trials, venetoclax has shown encouraging efficacy in patients with relapsed/refractory MM and t(11;14) [23, 24]. Here, we examined ...
Refractory Multiple Myeloma with At Least Two Prior Therapies in ...
Real-World Treatment Patterns and Outcomes in Patients with Relapsed/ ... treatment patterns, and clinical outcomes among RRMM patients who.
REAL-WORLD (RW) TREATMENT PATTERNS AND OUTCOMES IN ...
REAL-WORLD (RW) TREATMENT PATTERNS AND OUTCOMES IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) WITH AT LEAST ONE PRIOR THERAPY IN TURKEY.
Treatment patterns and outcomes of patients with relapsed or ...
After a median follow-up of 71 months (IQR 64–79) from index therapy, 5-year overall survival was 75% (95% CI 70–79), median progression-free ...
Treatment patterns and clinical outcomes among patients with ...
Half of the sample was stage III/IV at initial cHL diagnosis, and approximately 79.4% of cHL patients relapsed after their initial cHL diagnosis, compared with ...
Treatment Patterns and Outcomes in Patients with Relapsed or ...
Cite this ... Radford, John ; White, Ellie ; Castro, Felipe A. et al. / Treatment Patterns and Outcomes in Patients with Relapsed or Refractory ...
Treatment patterns and outcomes in relapsed/refractory follicular ...
The SCHOLAR-5 study examines treatment patterns and outcomes of real-world follicular lymphoma (FL) patients on 3rd line of treatment (LoT) or higher, ...